These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1656474)

  • 1. A kappa opiate agonist, U50,488H, enhances energy expenditure in rats.
    Mandenoff A; Seyrig JA; Betoulle D; Brigant L; Melchior JC; Apfelbaum M
    Pharmacol Biochem Behav; 1991 May; 39(1):215-7. PubMed ID: 1656474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.
    Nencini P; Stewart J
    Brain Res; 1990 Sep; 527(2):254-8. PubMed ID: 2174718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats.
    Hoffman DC; West TE; Wise RA
    Brain Res; 1991 Jun; 550(2):205-12. PubMed ID: 1653084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts.
    Xia Q; Sheng JZ; Tai KK; Wong TM
    J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic administration of U50,488H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats.
    Ignar DM; Windh RT; Kuhn CM
    Neuropharmacology; 1992 Feb; 31(2):143-8. PubMed ID: 1553027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kappa-opioid U-50,488H suppresses the initiation of nocturnal spontaneous drinking in normally hydrated rats.
    Badiani A; Stewart J
    Psychopharmacology (Berl); 1992; 106(4):463-73. PubMed ID: 1315973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
    Czlonkowski A; Millan MJ; Herz A
    Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
    [No Abstract]   [Full Text] [Related]  

  • 12. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary modulation of mu and kappa opioid receptor-mediated analgesia.
    Kanarek RB; Przypek J; D'Anci KE; Marks-Kaufman R
    Pharmacol Biochem Behav; 1997 Sep; 58(1):43-9. PubMed ID: 9264068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
    Bhargava HN; Matwyshyn G; Ramarao P
    Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
    Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
    Bhargava HN; Gulati A; Ramarao P
    Pharmacology; 1991; 42(3):121-7. PubMed ID: 1647533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa- and delta-opioid agonists synergize to produce potent analgesia.
    Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1990 Feb; 509(1):165-8. PubMed ID: 2155044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.